The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
酪氨酸激酶抑制剂治疗日本慢性粒细胞白血病患者血管不良事件的发生率及新型风险评估工具的实用性
期刊:Cardiooncology
影响因子:3.2
doi:10.1186/s40959-025-00366-x
Watanabe, Naoki; Takaku, Tomoiku; Iriyama, Noriyoshi; Iwanaga, Eisaku; Kimura, Yuta; Ishikawa, Maho; Nakayama, Hitomi; Sato, Eriko; Tabayashi, Takayuki; Mitsumori, Toru; Nakazato, Tomonori; Tokuhira, Michihide; Fujita, Hiroyuki; Ando, Miki; Miura, Katsuhiro; Kawaguchi, Tatsuya